英文誌(2004-)
Case Report(症例報告)
(0187 - 0192)
未分化転化にともない著明な超音波所見の変化を観察し得た甲状腺癌の1例
A Case of Anaplastic Thyroid Cancer Transformed From the Papillary Type With Characteristic Changes in Ultrasonographic Findings
山崎 幸司1, 平田 経雄1, 藤川 潤2, 大田 政之3, 岡村 建2, 浅野 有2, 佐藤 薫2, 黒田 健郎2, 溝上 哲也2
Kouji YAMASAKI1, Tsuneo HlRATA1, Megumi FUJIKAWA2, Masayuki OHTA3, Ken OKAMURA2, Tamotsu ASANO2, Kaori SATOH2, Takeo KURODA2, Tetsuya MIZOKAMI2
1九州大学医学部附属病院超音波室, 2九州大学医学部附属病院第2内科, 3九州大学医学部附属病院病理部
1Division of Diagnostic Ultrasound Kyushu University Hospital, 2Second Department of Internal Medicine Kyushu University Hospital, 3Department of Clinical Pathology Kyushu University Hospital
キーワード : Anaplastic carcinoma, Thyroid cancer, Ultrasonography
A 75-year-old man with thyroid tumor that had metastasized to the lung was admitted to this institution in a condition of cardiac failure. Aspiration biopsy of the thyroid mass showed hypoplastic papillary carcinoma, and a diagnosis of Graves'disease was made through serum-function studies and titers of TBII and TSAb during the course of hospitalization. The patient refused to undergo thyroidectomy, but ultrasonography was used to observe the lesion on six occasions. Volume, estimated using the formula for a rotated ellipse, was 16.7 cm³ on hospital days 1 and 71, 66.6 cm³ on day 167, 112.9 cm³ on day 188, 128.7 cm³ on day 195, and 219.8 cm³ on day 203. Ultrasonographic findings suggested a diagnosis of papillary carcinoma of the thyroid on days 1 and 71, but on day 167 the shape of the tumor began to change from that of an irregular star to one resembling a clover-leaf; its final shape was round. The source of multiple small, strong echoes from the center of the tumor on day 1 had gradually shifted to the margin of the tumor by day 167. On day 203, aspiration biopsy of the thyroid confirmed the diagnosis of anaplastic carcinoma. These observations suggest that rapid growth and change in shape of an irregular thyroid nodule may be characteristic ultrasonographic findings indicative of anaplastic transformation in thyroid cancer.